2,4-Dichloro-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine
Names and Identifiers of 1000578-08-4
CAS Number |
1000578-08-4 |
|---|---|
IUPAC Name |
2,4-dichloro-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine |
InChI |
InChI=1S/C7H7Cl2N3/c8-6-4-1-2-10-3-5(4)11-7(9)12-6/h10H,1-3H2 |
InChIKey |
IPSIICUFLIHDCA-UHFFFAOYSA-N |
Canonical SMILES |
C1CNCC2=C1C(=NC(=N2)Cl)Cl |
Physical and chemical properties of 1000578-08-4
Acidity coefficient |
5.88±0.20(Predicted) |
|---|---|
Boiling Point |
354.0±42.0 °C at 760 mmHg |
Density |
1.4±0.1 g/cm3 |
Exact Mass |
203.001709 |
Flash Point |
167.9±27.9 °C |
Index of Refraction |
1.584 |
LogP |
0.34 |
Melting Point |
>200°C (dec.) |
Molecular Formula |
C7H7Cl2N3 |
Molecular Weight |
204.057 |
PSA |
37.81000 |
Solubility |
Methanol (Slightly), Water (Slightly) |
Stability |
Hygroscopic |
Storage condition |
2-8°C |
Vapour Pressure |
0.0±0.8 mmHg at 25°C |
Safety Information of 1000578-08-4
Applications of 1000578-08-4
The applications of 2,4-Dichloro-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine are diverse:
- Pharmaceutical Development: It serves as an intermediate in the synthesis of various bioactive compounds and pharmaceuticals.
- Chemical Research: Utilized as a catalyst or building block for more complex organic molecules.
- Material Science: It has potential uses in producing specialized chemical products and materials due to its unique properties.
Interaction Studies of 1000578-08-4
Research indicates that 2,4-Dichloro-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine interacts primarily with PARP enzymes and components of the mTOR signaling pathway. These interactions suggest that it may enhance the efficacy of certain chemotherapeutic agents by promoting DNA damage accumulation in cancer cells. Furthermore, studies have shown that environmental factors such as storage conditions (ideally at 2-8°C) can influence its stability and efficacy.
Biological Activity of 1000578-08-4
2,4-Dichloro-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine exhibits significant biological activity, particularly as an inhibitor of poly(ADP-ribose) polymerase (PARP). By inhibiting PARP, the compound disrupts DNA repair mechanisms, leading to increased DNA damage and triggering apoptosis in cancer cells. Additionally, it interacts with key signaling pathways, notably the PI3K/Akt/mTOR pathway, which is crucial for cell growth and proliferation. This interaction suggests potential therapeutic applications in oncology.
